SLONKOVA, Jana, Milos CHUDY, Ariunjargal TOGTOKHJARGAL, Hana TOMASKOVA, Hana VACOVSKA, Gisela RYTIROVA a Irena DOLEŽALOVÁ. The effects of COVID-19 on sleep and general health of Czech patients with epilepsy. Heliyon. Oxford: Elsevier, 2023, roč. 9, č. 2, s. 1-8. ISSN 2405-8440. Dostupné z: https://dx.doi.org/10.1016/j.heliyon.2023.e13413.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název The effects of COVID-19 on sleep and general health of Czech patients with epilepsy
Autoři SLONKOVA, Jana (203 Česká republika), Milos CHUDY (203 Česká republika), Ariunjargal TOGTOKHJARGAL (203 Česká republika), Hana TOMASKOVA (203 Česká republika), Hana VACOVSKA (203 Česká republika), Gisela RYTIROVA (203 Česká republika) a Irena DOLEŽALOVÁ (203 Česká republika, domácí).
Vydání Heliyon, Oxford, Elsevier, 2023, 2405-8440.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30210 Clinical neurology
Stát vydavatele Velká Británie a Severní Irsko
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 4.000 v roce 2022
Kód RIV RIV/00216224:14110/23:00133825
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1016/j.heliyon.2023.e13413
UT WoS 000969339100001
Klíčová slova anglicky COVID-19; sleep; epilepsy
Štítky 14110127, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 19. 3. 2024 09:11.
Anotace
Objectives: To assess the impact of COVID-19 illness and pandemic era on sleep, general health, health care, and social status in patients with epilepsy in the Czech Republic.Methods: Our designed and approved questionnaire consisted of 23 questions. We focused on (1) patients' demographic and epidemiological data regarding COVID-19, (2) subjective assessment of sleep; (3) epilepsy, and (4) perception of general health during the first year of the COVID-19 pandemic in the Czech Republic from March 2020 to May 2021. We administered the questionnaires during outpatient visits or by phone calls in three major university Czech epilepsy centers (Ostrava, Brno, Pilsen).Results: We enrolled 227 (100%) patients. The mean age (+/- SD) was 41.2 +/- 14.82 years (min 18, max 86 years), and 138 (61%) were women. COVID-19 was confirmed using the PCR test method in 57 (25.1%) patients. In the pre-pandemic era, 62 (27.3%) patients reported sleep distur-bances. Insomnia in 46 (74.2%) and excessive daytime sleepiness in 6 (9.7%) were the most mentioned sleep abnormalities. Nocturnal seizures predispose to sleep impairment (p = 0.014) and vivid dreams and nightmares (p = 0.033). COVID-19 infection significantly increased the risk of vivid dreams and nightmares in patients with diurnal seizures (p = 0.006). Sleep quality impairment and seizure frequency worsening [(p < 0.001) and (p = 0.001), respectively] were the most significant risk factors to perform general health deterioration regardless of having COVID-19 (p = 0.559). The most affected age group was 51+ years (p = 0.033). The three centers provided adequate outpatient care during the first year of the pandemic. The employment and social status of the patients remained unchanged (p = 0.074).Conclusions: COVID-19 infection significantly increased the occurrence of vivid dreams and nightmares in patients with diurnal seizures. Sleep quality deterioration and seizure frequency worsening significantly negatively impacted general health performance.
VytisknoutZobrazeno: 21. 7. 2024 05:27